Generic drugs in South Korea are registered through the Ministry of Food and Drug Safety (MFDS). The process involves submitting data proving bioequivalence to the reference drug, along with manufacturing details that meet Good Manufacturing Practice (GMP) standards. Regulatory review ensures the generic drug’s safety, efficacy, and quality before approval for market entry.
